Delivery Order SPE2DB22D1103-SPE2DB25FH3E6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,437.98 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $71,465.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $9,840.04 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $40,974.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication that represents part of the broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,108.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $2,060.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pens valued at $10,961.03 on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,681.38 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price delivery order requires fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location and represents no set-aside designation. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's role...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3E6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,042.68 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent with AmerisourceBergen's role as a primary pharmaceutical distributor for federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a child order under this comprehensive prime vendor agreement, the award leverages the established vehicle to provide pharmaceutical products and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The IDC arrangement enables efficient procurement of critical medical commodities across multiple therapeutic domains while maintaining pricing stability through firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/25/25 |